Cayman Chemical Partners with Akadeum for Advanced Cell Isolation

Cayman Chemical has partnered with Akadeum Life Sciences to distribute Akadeum's innovative microbubble cell isolation kits, announced in a press release. This collaboration aims to expand the availability of Akadeum's next-generation cell isolation technology, which is crucial for advancing cell and gene therapy development.

Akadeum's buoyancy-based microbubble technology offers a faster and gentler method for isolating cells from mixed populations, ensuring high purity and cell health. This approach is the first new cell separation modality in over 40 years, providing a significant improvement over traditional methods. The kits are designed to integrate seamlessly into existing workflows, enhancing recovery and viability of isolated cell populations.

The partnership leverages Cayman's extensive distribution network to make Akadeum's technology accessible to researchers worldwide, supporting advancements in various scientific fields. Akadeum's CEO, Brandon McNaughton, emphasized the importance of this collaboration in providing scientists with effective tools for cell separation, ultimately driving progress in cell and gene therapy research.